Goodman D M, Nemoto E M, Evans R W, Winter P M
Department of Anesthesiology and Critical Care Medicine, University of Pittsburgh, School of Medicine, PA 15261, USA.
Chem Phys Lipids. 1996 Nov 1;84(1):57-64. doi: 10.1016/s0009-3084(96)02618-7.
Anesthetics are believed to produce anesthesia through the reversible inhibition of synaptic transmission but how this is accomplished is unknown. Based on earlier studies of anesthetic-enzyme-phospholipid interaction, we surmised that anesthetics may inhibit synaptic transmission by increasing synaptic membrane lateral pressure thereby inhibiting phospholipid hydrolysis, membrane transduction and synaptic transmission. As a first approximation towards investigating this concept, we hypothesized that anesthetics modulate the rate of phospholipase C hydrolysis of a lipid monolayer through its effects on surface pressure. The relationship between the hydrolysis rate of a monolayer of dipalmitoylphosphatidylcholine [14C-choline] (DPPC) by phospholipase C (Plase C) and monolayer surface pressure (SP) as altered by either halothane, isoflurane, or by physical compression at 37 degrees C was studied. The decline in surface 14C-activity as the [14C]choline diffuses into the Krebs-Ringer bicarbonate buffer aqueous subphase is estimated as the rate of DPPC hydrolysis measured by the initial slope method. DPPC hydrolysis was about 300 cpm/min and constant between SP of 0 to 20 dynes/cm. Higher SP between 25 and 30 dyne/cm, whether induced by halothane, isoflurane or physical compression, increased the rate of hydrolysis by 5-fold to a peak rate of about 1600 cpm/min at 25-30 dynes/cm. At a SP above 32 dynes/cm, DPPC hydrolysis abruptly ceased. We conclude that anesthetics can reversibly inhibit synaptic transmission through their effects on synaptic membrane lateral pressure. We also speculate that membrane lateral pressure may be a highly sensitive means of controlling membrane function through alteration in membrane lipid composition, membrane enzyme activity, receptor affinity and ion channel permeability.
人们认为麻醉剂通过可逆性抑制突触传递来产生麻醉作用,但具体机制尚不清楚。基于早期对麻醉剂 - 酶 - 磷脂相互作用的研究,我们推测麻醉剂可能通过增加突触膜侧向压力来抑制突触传递,从而抑制磷脂水解、膜转导和突触传递。作为研究这一概念的初步近似方法,我们假设麻醉剂通过影响表面压力来调节脂质单层中磷脂酶C的水解速率。研究了在37℃下,氟烷、异氟烷或物理压缩改变二棕榈酰磷脂酰胆碱[14C - 胆碱](DPPC)单层的表面压力(SP)时,磷脂酶C(Plase C)对其水解速率的影响。当[14C]胆碱扩散到 Krebs - Ringer 碳酸氢盐缓冲液水相中时,表面14C活性的下降被估计为通过初始斜率法测量的DPPC水解速率。DPPC水解速率约为300 cpm/min,在0至20达因/厘米的表面压力之间保持恒定。在25至30达因/厘米之间的较高表面压力下,无论是由氟烷、异氟烷还是物理压缩引起的,水解速率都增加了5倍,在25 - 30达因/厘米时达到约1600 cpm/min的峰值速率。在表面压力高于32达因/厘米时,DPPC水解突然停止。我们得出结论,麻醉剂可通过对突触膜侧向压力的影响来可逆性抑制突触传递。我们还推测,膜侧向压力可能是通过改变膜脂质组成、膜酶活性、受体亲和力和离子通道通透性来控制膜功能的一种高度敏感的方式。